Comparative Bioavailability Study of Lamotrigine ER Tablets USP 50 mg
Status:
Completed
Trial end date:
2018-02-21
Target enrollment:
Participant gender:
Summary
Objective:
To evaluate and compare the bioavailability and therefore to assess the bioequivalence of two
different formulations of lamotrigine after a single oral dose administration under fasting
conditions.
The secondary objective is to monitor the safety of the subjects.